Initial Pharmacological Interventions for ADHD

First-Line Treatment Options

Stimulant medications, such as methylphenidate and amphetamines, are the first-line pharmacological treatment for ADHD due to their superior efficacy, rapid onset of action, and extensive evidence base, as recommended by the American Academy of Pediatrics 1
Methylphenidate formulations are the most commonly prescribed first-line medications for ADHD across multiple countries and guidelines, with available formulations including immediate-release, extended-release, and osmotic-release oral system methylphenidate 2, 3
Amphetamine formulations, including lisdexamfetamine, are also considered first-line options with similar efficacy to methylphenidate, according to the American Academy of Child and Adolescent Psychiatry 1

For children and adolescents up to 70 kg, the American Academy of Pediatrics recommends starting methylphenidate at lower doses, approximately 5-10 mg/day, and titrating gradually while monitoring side effects and improvement 2, 3
The maximum recommended dose of methylphenidate varies by formulation, with a range of 60-72 mg/day, as recommended by the National Institute of Mental Health 2, 3

Atomoxetine, a norepinephrine reuptake inhibitor, is the primary second-line treatment when stimulants are ineffective or poorly tolerated, according to the American Academy of Child and Adolescent Psychiatry 1
Alpha-2 adrenergic agonists, such as clonidine and guanfacine, are established non-stimulant options with evidence supporting their efficacy, as recommended by the American Academy of Pediatrics 1

The treatment algorithm recommends starting with FDA-approved stimulant medications, such as methylphenidate or amphetamine formulations, as the first-line treatment, according to the American Academy of Child and Adolescent Psychiatry 1
If the first stimulant is ineffective or poorly tolerated, an alternative stimulant medication or formulation should be tried, as recommended by the National Institute of Mental Health 4, 1

Non-stimulants, such as atomoxetine, have a slower onset of action, typically 6-12 weeks, compared to stimulants, which have a rapid onset of action, according to the American Academy of Pediatrics 4
Stimulants may cause rebound symptoms when effects wear off, and common side effects include sleep disturbances, decreased appetite, and cardiovascular effects, such as increased blood pressure and pulse, as reported by the National Institute of Mental Health 4

Regular monitoring of vital signs, such as blood pressure and pulse, is recommended, especially with stimulant medications, according to the American Academy of Pediatrics 4
Effectiveness should be evaluated based on reduction in core ADHD symptoms and improvement in functioning, as recommended by the National Institute of Mental Health 2